Laëtitia Stefani
Impact in
- Geriatrics and Gerontology top 2%
- Frailty in Older Adults
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Papers in
- Oncology 14
- Cancer survivorship and care 4
- HER2/EGFR in Cancer Research 3
-
- Frailty in Older Adults 4
- Co-authors
- Olivier Trédan (5 shared papers)Eric Pujade Lauraine (5 shared papers)Beatrice E. Weber (2 shared papers)Gilles Freyer (4 shared papers)Christine Rebischung (2 shared papers)Mireille Mousseau (3 shared papers)Fabien Subtil (1 shared paper)Thierry LECOMTE (1 shared paper)
In The Last Decade
Laëtitia Stefani
40 papers receiving 1.2k citations
Laëtitia Stefani's Hit Papers
Peers
Comparison fields: 5 of 78
- Geriatrics and Gerontology 149
- Otorhinolaryngology 109
- Oncology 489
- Reproductive Medicine 110
- Internal Medicine 39
Countries citing papers authored by Laëtitia Stefani
This map shows the geographic impact of Laëtitia Stefani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laëtitia Stefani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laëtitia Stefani more than expected).
Fields of papers citing papers by Laëtitia Stefani
This network shows the impact of papers produced by Laëtitia Stefani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laëtitia Stefani. The network helps show where Laëtitia Stefani may publish in the future.
Co-authors
The 25 scholars most cited alongside Laëtitia Stefani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 168 | |
| 2 | Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial Hit paper breakdown → | 2021 | 157 |
| 3 | 2019 | 104 | |
| 4 | 2013 | 95 | |
| 5 | 2015 | 78 | |
| 6 | 2006 | 62 | |
| 7 | 2018 | 56 | |
| 8 | 2021 | 54 | |
| 9 | 2006 | 49 | |
| 10 | 2005 | 46 | |
| 11 | 2017 | 44 | |
| 12 | 2008 | 42 | |
| 13 | 2018 | 38 | |
| 14 | 2016 | 32 | |
| 15 | 2016 | 24 | |
| 16 | 2022 | 22 | |
| 17 | 2018 | 16 | |
| 18 | 2020 | 13 | |
| 19 | 2022 | 13 | |
| 20 | 2017 | 12 |
About Laëtitia Stefani
Laëtitia Stefani is a scholar working on Oncology, Geriatrics and Gerontology, Surgery, Pulmonary and Respiratory Medicine and Hematology, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Frailty in Older Adults (4 papers), Cancer survivorship and care (4 papers), Estrogen and related hormone effects (3 papers), HER2/EGFR in Cancer Research (3 papers), Nutrition and Health in Aging (3 papers), Healthcare Systems and Practices (2 papers), Health, Medicine and Society (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Geriatrics and Gerontology (149 citations), Otorhinolaryngology (109 citations), Oncology (489 citations), Reproductive Medicine (110 citations) and Internal Medicine (39 citations). Laëtitia Stefani has collaborated with scholars based in France, Italy and Canada. Frequent co-authors include Olivier Trédan, Eric Pujade Lauraine, Beatrice E. Weber, Gilles Freyer, Christine Rebischung, Mireille Mousseau, Fabien Subtil, Thierry LECOMTE, Mohamed Gasmi and Jean‐François Seitz. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, BMC Cancer, The Lancet and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.